| 
Results for it101. Search took 0.08 seconds.
Nanoparticle anti-cancer drug tested on humans
in Nanotechbuzz, on July 21, 2006
Insert Therapeutics has treated its first patient in a Phase I study of IT-101, its lead anti-cancer compound, says a company press release :
The study involves patients with inoperable or metastatic solid tumors and has been designed to evaluate the safety, tolerability and pharmacok...